French pharmaceutical company said drug could treat COVID-19 patients after promising test results
A leading French pharmaceutical company said it could potentially treat 300,000 COVID-19 patients with the anti-malarial drug Plaquenil after what it described as “promising” test results.
Sanofi said it was ready to offer France millions of doses of Plaquenil, a spokesperson for the laboratory told AFP, adding that the group was ready to work with French health authorities “to confirm these results.”
The study on 24 patients with coronavirus using Plaquenil, a hydroxychloroquine molecule, which has also been used for decades for the treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Six days after the start of taking Plaquenil, the virus had disappeared in three-quarters of those treated, said Professor Didier Raoult, who is director of the Institut Hospitalo-Universitaire de Marseille.
The French government said the clinical trials were “promising” and would be extended to more patients.
You may be interested
Greek Resort named top “World’s Leading Luxury Green Resort”Panos - Dec 01, 2020
Sani Resort in Kassandra, Halkidiki gained the top spot as the “World’s Leading Luxury Green Resort” at the World Travel…
Greeks pay over half a million euros in Covid-19 fines in a dayPanos - Dec 01, 2020
Greeks were fined a total of over half a million Euros for violating Covid-19 measures following intensive police inspections on…
Hellenic Civil Aviation Authority extends Covid-19 directives until December 7 and 14Panos - Dec 01, 2020
The Hellenic Civil Aviation Authority (HCAA) extended the Covid-19 directives for domestic flights until Monday 7 December 2020 and for…